Julian Buchrieser

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with nuclear speckles.

Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with nuclear speckles.

Journal: eLife
Published: January 06, 2026

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.

Journal: Nature communications
Published: November 07, 2025

Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection.

Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection.

Journal: Cell
Published: January 30, 2025

Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with the nuclear speckle.

Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with the nuclear speckle.

Journal: bioRxiv : the preprint server for biology
Published: December 16, 2024

SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.

SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.

Journal: Journal of virology
Published: November 21, 2024

MECHANISMS OF TECOVIRIMAT ANTIVIRAL ACTIVITY AND POXVIRUS RESISTANCE.

MECHANISMS OF TECOVIRIMAT ANTIVIRAL ACTIVITY AND POXVIRUS RESISTANCE.

Journal: Research square
Published: October 14, 2024

Structural insights into tecovirimat antiviral activity and poxvirus resistance.

Structural insights into tecovirimat antiviral activity and poxvirus resistance.

Journal: Nature microbiology
Published: August 30, 2024

Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.

Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.

Journal: The Lancet. Infectious diseases
Published: July 12, 2024

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.

Journal: Journal of virology
Published: April 02, 2024

Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus.

Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus.

Journal: Cell
Published: February 14, 2024

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.

Journal: Nature communications
Published: December 14, 2023

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

Journal: Journal of virology
Published: December 13, 2023
Showing 1-12 of 41

Last Updated: 09/26/2026